Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Literature DB >> 10655415

Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

E Mahenthiralingam¹, T Coenye, J W Chung, D P Speert, J R Govan, P Taylor, P Vandamme.

Abstract

Two new species, Burkholderia multivorans and Burkholderia vietnamiensis, and three genomovars (genomovars I, III, and IV) currently constitute the Burkholderia cepacia complex. A panel of 30 well-characterized strains representative of each genomovar and new species was assembled to assist with identification, epidemiological analysis, and virulence studies on this important group of opportunistic pathogens.

Entities: Species

Mesh：

Year: 2000 PMID： 10655415 PMCID： PMC86244

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

30 in total

Review 1. Burkholderia cepacia. Management issues and new insights.

Authors: J J LiPuma
Journal: Clin Chest Med Date: 1998-09 Impact factor: 2.878

2. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.

Authors: J J LiPuma; J E Mortensen; S E Dasen; T D Edlind; D V Schidlow; J L Burns; T L Stull
Journal: J Pediatr Date: 1988-11 Impact factor: 4.406

3. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis.

Authors: G Y Larsen; T L Stull; J L Burns
Journal: J Clin Microbiol Date: 1993-04 Impact factor: 5.948

4. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients.

Authors: L Millar-Jones; H C Ryley; A Paull; M C Goodchild
Journal: Respir Med Date: 1998-02 Impact factor: 3.415

5. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa.

Authors: S E West; H P Schweizer; C Dall; A K Sample; L J Runyen-Janecky
Journal: Gene Date: 1994-10-11 Impact factor: 3.688

6. Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI.

Authors: S Lewenza; B Conway; E P Greenberg; P A Sokol
Journal: J Bacteriol Date: 1999-02 Impact factor: 3.490

7. Multiple replicons constituting the genome of Pseudomonas cepacia 17616.

Authors: H P Cheng; T G Lessie
Journal: J Bacteriol Date: 1994-07 Impact factor: 3.490

8. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers.

Authors: U S Sajjan; L Sun; R Goldstein; J F Forstner
Journal: J Bacteriol Date: 1995-02 Impact factor: 3.490

9. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.

Authors: I N Simpson; J Finlay; D J Winstanley; N Dewhurst; J W Nelson; S L Butler; J R Govan
Journal: J Antimicrob Chemother Date: 1994-09 Impact factor: 5.790

10. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.

Authors: D P Speert; M Bond; R C Woodman; J T Curnutte
Journal: J Infect Dis Date: 1994-12 Impact factor: 5.226

152 in total

1. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors: D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal: J Clin Microbiol Date: 2001-03 Impact factor: 5.948

Review 2. Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors: J R Govan
Journal: J R Soc Med Date: 2000 Impact factor: 5.344

Review 3. Taxonomy and identification of the Burkholderia cepacia complex.

Authors: T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal: J Clin Microbiol Date: 2001-10 Impact factor: 5.948

4. Identification of quorum-sensing-regulated genes of Burkholderia cepacia.

Authors: Claudio Aguilar; Arianna Friscina; Giulia Devescovi; Milan Kojic; Vittorio Venturi
Journal: J Bacteriol Date: 2003-11 Impact factor: 3.490

5. Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil.

Authors: Maria G Detsika; John E Corkill; Marcelo Magalhães; Kerry J Glendinning; C Anthony Hart; Craig Winstanley
Journal: J Clin Microbiol Date: 2003-09 Impact factor: 5.948

Review 6. Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis.

Authors: Deborah A Miller; Eshwar Mahenthiralingam
Journal: J R Soc Med Date: 2003 Impact factor: 5.344

Review 7. Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors: Andrew M Jones; A Kevin Webb
Journal: J R Soc Med Date: 2003 Impact factor: 5.344

8. Direct PCR detection of Burkholderia cepacia complex and identification of its genomovars by using sputum as source of DNA.

Authors: Pavel Drevínek; Hana Hrbácková; Ondrej Cinek; Jana Bartosová; Otakar Nyc; Alexandr Nemec; Petr Pohunek
Journal: J Clin Microbiol Date: 2002-09 Impact factor: 5.948

9. Species abundance and diversity of Burkholderia cepacia complex in the environment.

Authors: Alban Ramette; John J LiPuma; James M Tiedje
Journal: Appl Environ Microbiol Date: 2005-03 Impact factor: 4.792

10. Developing an international Pseudomonas aeruginosa reference panel.

Authors: Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal: Microbiologyopen Date: 2013-11-11 Impact factor: 3.139